Similar articles

• Nonparathyroid humoral hypercalcemia in patients with neoplastic diseases.

  Powell D, Singer FR, Murray TM, Minkin C, Potts JT Jr. Powell D, et al. N Engl J Med. 1973 Jul 26;289(4):176-81. doi: 10.1056/NEJM197307262890403. N Engl J Med. 1973. PMID: 4712989 No abstract available.
• [Serum levels of osteocalcin in hypercalcemia caused by primary hyperparathyroidism and in tumor hypercalcemia].

  de la Piedra C, Rapado A, Esbrit P. de la Piedra C, et al. Rev Clin Esp. 1985 Nov;177(7):310-3. Rev Clin Esp. 1985. PMID: 3878548 Spanish. No abstract available.
• Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia.

  Audran M, Minebois-Villégas A, Lortholary A, Legrand E, Pascaretti C, Giraud P, Subra JF, Boasson M, Jallet P. Audran M, et al. Rev Rhum Engl Ed. 1995 Mar;62(3):189-96. Rev Rhum Engl Ed. 1995. PMID: 7788336
• [Clinical signs and laboratory findings in primary hyperthyroidism].

  Nikkilä M, Saaristo J. Nikkilä M, et al. Duodecim. 1989;105(4):356-62. Duodecim. 1989. PMID: 2649369 Review. Finnish. No abstract available.
• Primary hyperparathyroidism: pathogenesis, diagnosis, and management.

  Chapman I, Horowitz M, Need AG, Morris HA. Chapman I, et al. Compr Ther. 1988 Sep;14(9):65-73. Compr Ther. 1988. PMID: 3064963 Review. No abstract available.